Back to Search
JUNELYN LAZO, PH.D, BCBA-D
PH.D, BCBA-D
Behavior Analyst
NPI: 1295113306Individual
Specialties, Licenses & Credentials
Behavior AnalystPrimary
Behavior Analyst
Code: 103K00000X
1-04-1570(CA)
Research & Publications (20)
Building a pharmacological lexicon: small molecule discovery in academia.
PMID 17405872·Mol Pharmacol·2007
6-review
Structurally unique inhibitors of human mitogen-activated protein kinase phosphatase-1 identified in a pyrrole carboxamide library.
PMID 17538006·J Pharmacol Exp Ther·2007
8-other
In the forefront of basic and translational cancer research - 7th AACR-JCA Joint International Conference.
PMID 17390238·IDrugs·2007
8-other
The substrate recognition domains of the N-end rule pathway.
PMID 19008229·J Biol Chem·2009
7-preclinical
Zebrafish chemical screening reveals an inhibitor of Dusp6 that expands cardiac cell lineages.
PMID 19578332·Nat Chem Biol·2009
7-preclinical
Nitrosative stress suppresses checkpoint activation after DNA synthesis inhibition.
PMID 19158509·Cell Cycle·2009
8-other
Bioactivities of simplified adociaquinone B and naphthoquinone derivatives against Cdc25B, MKP-1, and MKP-3 phosphatases.
PMID 19028102·Bioorg Med Chem·2009
8-other
Efficacy, pharmacokinetics, tisssue distribution, and metabolism of the Myc-Max disruptor, 10058-F4 [Z,E]-5-[4-ethylbenzylidine]-2-thioxothiazolidin-4-one, in mice.
PMID 18509642·Cancer Chemother Pharmacol·2009
7-preclinical
Microtubule binding and disruption and induction of premature senescence by disorazole C(1).
PMID 19066338·J Pharmacol Exp Ther·2009
7-preclinical
Comparative study of the removal of phenolic compounds by biological and non-biological adsorbents.
PMID 18990486·J Hazard Mater·2009
4-observational
Automated image-based phenotypic analysis in zebrafish embryos.
PMID 19235725·Dev Dyn·2009
7-preclinical
Cdc25B dual-specificity phosphatase inhibitors identified in a high-throughput screen of the NIH compound library.
PMID 19530895·Assay Drug Dev Technol·2009
8-other
Discovery of novel Myc-Max heterodimer disruptors with a three-dimensional pharmacophore model.
PMID 19215087·J Med Chem·2009
7-preclinical
Potent and selective disruption of protein kinase D functionality by a benzoxoloazepinolone.
PMID 18829454·J Biol Chem·2008
8-other
Computational design, synthesis and biological evaluation of para-quinone-based inhibitors for redox regulation of the dual-specificity phosphatase Cdc25B.
PMID 18802630·Org Biomol Chem·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 3000 S Hulen St Ste 124-851
Fort Worth, TX 76109 - Phone
- (844) 697-1907
Quick Facts
- NPI
- 1295113306
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 2
- Publications
- 20
Are you this provider?
Claim Your Profile